BG102779A - Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy - Google Patents

Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy

Info

Publication number
BG102779A
BG102779A BG102779A BG10277998A BG102779A BG 102779 A BG102779 A BG 102779A BG 102779 A BG102779 A BG 102779A BG 10277998 A BG10277998 A BG 10277998A BG 102779 A BG102779 A BG 102779A
Authority
BG
Bulgaria
Prior art keywords
type
receptors
compounds
hydrogen
thedopaminergic
Prior art date
Application number
BG102779A
Other languages
Bulgarian (bg)
Inventor
Mireille Sevrin
Benoit Marabout
Pascal George
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BG102779A publication Critical patent/BG102779A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to compounds with the general formulawhere R1, R2 & R3 means hydrogen or halogen atom or hydroxy, alkylor alkoxygroup, R4 is hydrogen or halogen atom or alkyl,2-methoxyethoxy, alkoxy, cycloalkylmethoxy or phenylmethoxygroup,or R3 & R4 together form methylenedioxy group, Z means oxygen ortwo hydrogen atoms and R is an ethoxygroup when Z is oxygen orphenyl group, optionally substituted by one or more atoms ofhalogen or alkyl, alkoxy or aminogroups. The compounds showaffinity to dopaminergetic receptors of the D2 and D3 type and toserotoninergic receptors of the 5-HT1A and 5-HT2 type and aremixed ligands. Other compounds have strong affinity to thedopaminergic receptors of the D3 type and poor affinity to thedopaminergic receptors of the D2 type and the serotoninergicreceptors of the 5-HT1A and 5-HT2 type, and, therofore, areselective and specific ligands.5 claims
BG102779A 1996-04-12 1998-09-18 Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy BG102779A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604565A FR2747386B1 (en) 1996-04-12 1996-04-12 DERIVATIVES OF 3 - [(1,2,3,4-TETRAHYDROISOQUINOLEIN-2-YL) METHYL] -8-AZABICYCLO [3.2.1] OCTANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1997/000634 WO1997038998A1 (en) 1996-04-12 1997-04-10 3-[(1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their application in therapeutics

Publications (1)

Publication Number Publication Date
BG102779A true BG102779A (en) 1999-09-30

Family

ID=9491132

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102779A BG102779A (en) 1996-04-12 1998-09-18 Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy

Country Status (22)

Country Link
EP (1) EP0892800A1 (en)
JP (1) JP2000512620A (en)
KR (1) KR20000005392A (en)
CN (1) CN1216046A (en)
AR (1) AR008587A1 (en)
AU (1) AU2640997A (en)
BG (1) BG102779A (en)
BR (1) BR9708654A (en)
CA (1) CA2251335A1 (en)
CO (1) CO4900067A1 (en)
CZ (1) CZ326898A3 (en)
EE (1) EE9800396A (en)
FR (1) FR2747386B1 (en)
IL (1) IL126473A0 (en)
NO (1) NO984736L (en)
NZ (1) NZ332257A (en)
PL (1) PL329243A1 (en)
SK (1) SK141598A3 (en)
TR (1) TR199801839T2 (en)
TW (1) TW407158B (en)
WO (1) WO1997038998A1 (en)
ZA (1) ZA973124B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102131790A (en) * 2008-06-27 2011-07-20 H.隆德贝克有限公司 Novel phenolic and catecholic amines and prodrugs thereof
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
MX2020007849A (en) 2018-01-26 2020-09-25 Shionogi & Co Condensed cyclic compound having dopamine d3 receptor antagonism.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2661178B1 (en) * 1990-04-24 1993-03-12 Synthelabo DERIVATIVES OF [(TETRAHYDRO-1,2,3,4 ISOQUINOLEINYL-2) METHYL] -4 PIPERIDINECARBOXYLATES-1 OF ALKYL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
KR20000005392A (en) 2000-01-25
NO984736L (en) 1998-11-23
IL126473A0 (en) 1999-08-17
NO984736D0 (en) 1998-10-09
JP2000512620A (en) 2000-09-26
NZ332257A (en) 1999-03-29
AU2640997A (en) 1997-11-07
CA2251335A1 (en) 1997-10-23
SK141598A3 (en) 1999-03-12
EP0892800A1 (en) 1999-01-27
PL329243A1 (en) 1999-03-15
BR9708654A (en) 1999-08-03
ZA973124B (en) 1997-11-05
CN1216046A (en) 1999-05-05
CZ326898A3 (en) 1999-01-13
FR2747386A1 (en) 1997-10-17
FR2747386B1 (en) 1998-05-15
WO1997038998A1 (en) 1997-10-23
TR199801839T2 (en) 1998-12-21
CO4900067A1 (en) 2000-03-27
EE9800396A (en) 1999-06-15
TW407158B (en) 2000-10-01
AR008587A1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
TW353072B (en) [1,3,4]triazolo [1,5-a] pyridines
AUPM666694A0 (en) Natural antifouling compositions
EP0776327A4 (en) New multimerizing agents
PL221249A1 (en)
ES8303411A1 (en) Theophylline and theobromine derivatives
EP0261912A3 (en) 2- or 3- Aryl substituted imidazo [1,2-a] pyridines
CO4700298A1 (en) DERIVATIVES OF 3-PHENYLISOKINOLEIN-1 (2H) -ONE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
BG103432A (en) Derivatives of 1,4-diazabicyclo[2.2.2]oct-2-ylmethylbenzoate, method for their preparation and application in therapy
BG102779A (en) Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy
IE813038L (en) Sweetening preparations, new 2, 4, 6-trihalogenated¹benzamides substituted in the 3-position.
ES8507536A1 (en) Quinazoline cardiac stimulants.
AU2964397A (en) N-bis- or n-tris-{(1,2-dicarboxy-ethoxy)-ethyl}-amine derivatives and preparation and use of the same
IE44316L (en) Indazole derivatives.
AU4002289A (en) Fused dibenzooxe (thie) pine derivatives.
PL329190A1 (en) Antagonists of alpha -adrenergic receptor
ES8705421A1 (en) 4-Amino-2-phenyl quinolines, methods and intermediates for their preparation and medicaments containing them.
DE3465082D1 (en) Pyridazinone derivatives, process for their preparation and their use as fungicides
ES8505682A1 (en) Beta-carbolin-3-carboxylic acid derivatives and methods of preparing them.
BG104309A (en) 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
PL263590A1 (en) Method of obtaining novel derivatives of bicyclo /4.2.0/octane
IE780982L (en) 4-hydroxythiazoline-2-thiones.
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
JPS5515455A (en) 2-substituted-methyl-1,4-benzodioxane
WO1996006851A3 (en) D-xylofuranose derivatives, method of preparing them, their use, and novel intermediate compounds for the method
ZA86543B (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics